D-1391-2019 Class III Terminated
FDA drug recall D-1391-2019 was initiated by Teligent Pharma, Inc. on May 20, 2019 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications The recall status is terminated (terminated Jan 27, 2025). Affected quantity: 9360 tubes.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 26, 2019
- Initiation Date
- May 20, 2019
- Termination Date
- Jan 27, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 9360 tubes
Product description
Betamethasone Dipropionate Ointment USP, 0.05%* (Augmented), a) 15 gram (NDC 52565-019-15) and b) 50 gram (NDC 52565-019-51) tubed, Rx Only, Manufactured by: Teligent Pharma, Inc. Buena, New Jersey 06310
Reason for recall
Failed Impurities/Degradation Specifications
Distribution pattern
Nationwide
Code information
Lot 11852, exp date 08/2020
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1391-2019
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026